CD8A and neoplasm: Recent studies have begun to assess the potential of manipulating metabolic pathways to alter differentiation status of CD8+ T cells17–19, but it remains unclear how these transcriptional and metabolic changes affect T cell differentiation to mediate anti-tumor efficacy.